ADVFN appoints Jason Paltrowitz as non-executive director
ADVFN Ltd is pleased to announce the appointment of Jason Paltrowitz as a Non-Executive Director. Jason brings more than 20 years of leadership experience across global capital markets, investor relations, exchange services, and corporate advisory.Listen to the HotCopper podcast for in-depth disc...
Market Cap $21.09M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
Filters
[Clear]
- Price Sensitive: Yes
| MYX | Mayne Pharma opens new US manufacturing facility | PRICE SENSITIVE | 18/04/18 | |
| MYX | Mayne Pharma launches Amiodarone 200mg tablets in the US | PRICE SENSITIVE | 17/04/18 | |
| MYX | Mayne Pharma's generic NuvaRing accepted for filing by FDA | PRICE SENSITIVE | 20/03/18 | |
| MYX | Mayne Pharma launches doxycycline IR capsules in the US | PRICE SENSITIVE | 16/03/18 | |
| MYX | First generic launch of Ritalin LA 10mg capsules in the US | PRICE SENSITIVE | 01/03/18 | |
| MYX | 2018 Half Year Media Release | PRICE SENSITIVE | 23/02/18 | |
| MYX Mayne Pharma opens new US manufacturing facility | |||
| 18/04/18 | PRICE SENSITIVE | ||
| MYX Mayne Pharma launches Amiodarone 200mg tablets in the US | |||
| 17/04/18 | PRICE SENSITIVE | ||
| MYX Mayne Pharma's generic NuvaRing accepted for filing by FDA | |||
| 20/03/18 | PRICE SENSITIVE | ||
| MYX Mayne Pharma launches doxycycline IR capsules in the US | |||
| 16/03/18 | PRICE SENSITIVE | ||
| MYX First generic launch of Ritalin LA 10mg capsules in the US | |||
| 01/03/18 | PRICE SENSITIVE | ||
| MYX 2018 Half Year Media Release | |||
| 23/02/18 | PRICE SENSITIVE | ||
